Globeflex Capital L P Makes New Investment in MKS Inc. $MKSI

Globeflex Capital L P purchased a new position in MKS Inc. (NASDAQ:MKSI) in the 2nd quarter, Holdings Channel reports. The institutional investor purchased 29,241 shares of the scientific and technical instruments company’s stock, valued at approximately $13,006,000. MKS comprises approximately 1.7% of Globeflex Capital L P’s investment portfolio, making the stock its 6th biggest holding.

Several other institutional investors have also modified their holdings of the business. Carolina Wealth Advisors LLC grew its position in shares of MKS by 47.5% in the 2nd quarter. Carolina Wealth Advisors LLC now owns 87 shares of the scientific and technical instruments company’s stock valued at $39,000 after purchasing an additional 28 shares during the period. Blue Trust Inc. raised its holdings in MKS by 1.1% during the 1st quarter. Blue Trust Inc. now owns 4,274 shares of the scientific and technical instruments company’s stock worth $982,000 after buying an additional 47 shares during the period. Covestor Ltd raised its holdings in MKS by 14.7% during the 4th quarter. Covestor Ltd now owns 390 shares of the scientific and technical instruments company’s stock worth $63,000 after buying an additional 50 shares during the period. Daiwa Securities Group Inc. lifted its stake in MKS by 10.4% in the fourth quarter. Daiwa Securities Group Inc. now owns 530 shares of the scientific and technical instruments company’s stock valued at $85,000 after buying an additional 50 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its stake in MKS by 1.3% in the fourth quarter. Quadrant Capital Group LLC now owns 4,335 shares of the scientific and technical instruments company’s stock valued at $693,000 after buying an additional 55 shares in the last quarter. Institutional investors own 99.79% of the company’s stock.

Insider Buying and Selling

In other MKS news, CEO John Tseng-Chung Lee sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $302.01, for a total value of $3,020,100.00. Following the completion of the transaction, the chief executive officer directly owned 134,776 shares in the company, valued at $40,703,699.76. This trade represents a 6.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP David Philip Henry sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $330.50, for a total value of $826,250.00. Following the completion of the transaction, the executive vice president owned 16,341 shares of the company’s stock, valued at approximately $5,400,700.50. This represents a 13.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 37,491 shares of company stock worth $12,102,072 over the last three months. Company insiders own 0.57% of the company’s stock.

MKS Price Performance

NASDAQ MKSI opened at $279.11 on Monday. The firm’s 50 day moving average is $341.95 and its 200-day moving average is $294.68. The company has a quick ratio of 0.72, a current ratio of 1.14 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $18.87 billion, a PE ratio of 44.52, a price-to-earnings-growth ratio of 0.59 and a beta of 1.98. MKS Inc. has a 12-month low of $97.50 and a 12-month high of $447.62.

MKS (NASDAQ:MKSI) last announced its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 EPS for the quarter, topping the consensus estimate of $2.91 by $0.39. The business had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.20 billion. MKS had a net margin of 10.15% and a return on equity of 24.72%. The firm’s revenue was up 28.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.77 earnings per share. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. Equities research analysts anticipate that MKS Inc. will post 12.96 earnings per share for the current fiscal year.

MKS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Tuesday, August 25th will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Tuesday, August 25th. MKS’s dividend payout ratio is currently 15.95%.

Wall Street Analyst Weigh In

MKSI has been the subject of several research reports. BMO Capital Markets assumed coverage on shares of MKS in a research report on Tuesday, June 30th. They set an “outperform” rating and a $453.00 price objective for the company. Wall Street Zen raised shares of MKS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Weiss Ratings raised shares of MKS from a “hold (c)” rating to a “buy (b-)” rating in a research note on Tuesday, August 11th. TD Cowen reissued a “buy” rating on shares of MKS in a research note on Thursday, May 7th. Finally, Bank of America boosted their price target on MKS from $380.00 to $500.00 and gave the company a “buy” rating in a report on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $385.00.

MKS Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.